A syringe is only one part of the cost of safe injectable treatment. Consultation time, genuine product, insurance, sterile consumables, regulated prescribing, clinical records, emergency readiness, follow-up and continuing education all sit behind the appointment.

Low wholesale cost proves very little

A lower product price may reflect direct distribution, scale or brand strategy. It may also come with a shorter independent evidence history or less clinical support. Profit margin alone does not prove that a filler is good or poor; neither does a premium logo.

Ask what is included

A very low headline price may depend on high-volume appointments, limited review, a fixed product regardless of anatomy, extra charges or little availability if a concern develops. Compare the complete care pathway, not only the number on the post.

Correction has a cost

Unwanted shape, migration, lumps or asymmetry may require review, ultrasound assessment, dissolving and a later reconstruction plan. A vascular event needs immediate expert management. Saving at the booking stage can become costly in money, time and anxiety.

A better value test

  • Is the exact product named and traceable?
  • Is it selected for this tissue and treatment plane?
  • Are risks, alternatives and likely maintenance explained?
  • Is the practitioner insured and contactable?
  • Does the price include appropriate review and complication care?

The bottom line

Choose on clinical value: appropriate product, careful technique, honest planning and accessible aftercare. Price is relevant, but it is not a safety certificate.

Editorial note: information checked August 2026. This article is general education, not personal medical advice. Suitability and risk must be assessed individually.